343 related articles for article (PubMed ID: 23979750)
41. Heterocyclyl tetracyclines. 2. 7-Methoxy-8-pyrrolidinyltetracyclines: discovery of TP-2758, a potent, orally efficacious antimicrobial against Gram-negative pathogens.
Sun C; Deng Y; Hunt DK; Fyfe C; Chen CL; Clark RB; Grossman TH; Sutcliffe JA; Xiao XY
J Antibiot (Tokyo); 2018 Feb; 71(2):287-297. PubMed ID: 28743974
[TBL] [Abstract][Full Text] [Related]
42. Multidrug-resistant bacteria isolated from patients hospitalised in Intensive Care Units.
Wroblewska MM; Rudnicka J; Marchel H; Luczak M
Int J Antimicrob Agents; 2006 Apr; 27(4):285-9. PubMed ID: 16545949
[TBL] [Abstract][Full Text] [Related]
43. In vitro activities of Eravacycline against 336 isolates collected from 2012 to 2016 from 11 teaching hospitals in China.
Zhao C; Wang X; Zhang Y; Wang R; Wang Q; Li H; Wang H
BMC Infect Dis; 2019 Jun; 19(1):508. PubMed ID: 31182038
[TBL] [Abstract][Full Text] [Related]
44. Eravacycline: a new treatment option for complicated intra-abdominal infections in the age of multidrug resistance.
Solomkin JS; Sway A; Lawrence K; Olesky M; Izmailyan S; Tsai L
Future Microbiol; 2019 Oct; 14():1293-1308. PubMed ID: 31570004
[No Abstract] [Full Text] [Related]
45. Resistance trends and in vitro activity of tigecycline and 17 other antimicrobial agents against Gram-positive and Gram-negative organisms, including multidrug-resistant pathogens, in Germany.
Kresken M; Becker K; Seifert H; Leitner E; Körber-Irrgang B; von Eiff C; Löschmann PA;
Eur J Clin Microbiol Infect Dis; 2011 Sep; 30(9):1095-103. PubMed ID: 21347680
[TBL] [Abstract][Full Text] [Related]
46.
Castanheira M; Davis AP; Mendes RE; Serio AW; Krause KM; Flamm RK
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866862
[TBL] [Abstract][Full Text] [Related]
47. Emergence of Carbapenem resistant Gram negative and vancomycin resistant Gram positive organisms in bacteremic isolates of febrile neutropenic patients: a descriptive study.
Irfan S; Idrees F; Mehraj V; Habib F; Adil S; Hasan R
BMC Infect Dis; 2008 Jun; 8():80. PubMed ID: 18541017
[TBL] [Abstract][Full Text] [Related]
48. In vitro activity of tigecycline against multiple-drug-resistant, including pan-resistant, gram-negative and gram-positive clinical isolates from Greek hospitals.
Souli M; Kontopidou FV; Koratzanis E; Antoniadou A; Giannitsioti E; Evangelopoulou P; Kannavaki S; Giamarellou H
Antimicrob Agents Chemother; 2006 Sep; 50(9):3166-9. PubMed ID: 16940120
[TBL] [Abstract][Full Text] [Related]
49. In vitro activity of tigecycline against 6792 Gram-negative and Gram-positive clinical isolates from the global Tigecycline Evaluation and Surveillance Trial (TEST Program, 2004).
Hoban DJ; Bouchillon SK; Johnson BM; Johnson JL; Dowzicky MJ;
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):215-27. PubMed ID: 16105567
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of Eravacycline: A Novel Fluorocycline.
Alosaimy S; Abdul-Mutakabbir JC; Kebriaei R; Jorgensen SCJ; Rybak MJ
Pharmacotherapy; 2020 Mar; 40(3):221-238. PubMed ID: 31944332
[TBL] [Abstract][Full Text] [Related]
51. [Antibibiotic resistance by nosocomial infections' causal agents].
Salazar-Holguín HD; Cisneros-Robledo ME
Rev Med Inst Mex Seguro Soc; 2016; 54(4):462-71. PubMed ID: 27197104
[TBL] [Abstract][Full Text] [Related]
52. Doripenem: an expected arrival in the treatment of infections caused by multidrug-resistant Gram-negative pathogens.
Poulakou G; Giamarellou H
Expert Opin Investig Drugs; 2008 May; 17(5):749-71. PubMed ID: 18447600
[TBL] [Abstract][Full Text] [Related]
53. [Microbiological and resistance profiles of community acquired and nosocomial intra abdominal infections in surgery of National Hospital Guillermo Almenara, Lima, Peru].
Revoredo Rego F; Huamán Egoávil E; Zegarra Cavani S; Auris Mora H; Valderrama Barrientos R
Rev Gastroenterol Peru; 2016; 36(2):115-22. PubMed ID: 27409087
[TBL] [Abstract][Full Text] [Related]
54. Comparative activity of meropenem in US medical centers (2007): initiating the 2nd decade of MYSTIC program surveillance.
Jones RN; Kirby JT; Rhomberg PR
Diagn Microbiol Infect Dis; 2008 Jun; 61(2):203-13. PubMed ID: 18329835
[TBL] [Abstract][Full Text] [Related]
55. Antimicrobial susceptibility pattern of bacteria isolated from patients with urinary tract infection.
Khan IU; Mirza IA; Ikram A; Afzal A; Ali S; Hussain A; Fayyaz M; Ghafoor T
J Coll Physicians Surg Pak; 2014 Nov; 24(11):840-4. PubMed ID: 25404444
[TBL] [Abstract][Full Text] [Related]
56. In vitro activity of tigecycline and comparators against Gram-positive and Gram-negative isolates collected from the Middle East and Africa between 2004 and 2011.
Kanj SS; Whitelaw A; Dowzicky MJ
Int J Antimicrob Agents; 2014 Feb; 43(2):170-8. PubMed ID: 24315313
[TBL] [Abstract][Full Text] [Related]
57. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
[TBL] [Abstract][Full Text] [Related]
58. [Surveillance of antimicrobial resistance of bacteria isolated from bloodstream infections: data of the French National Observatory for Epidemiology of Bacterial Resistance to Antibiotics (ONERBA), 1998-2003].
Bertrand X; Costa Y; Pina P
Med Mal Infect; 2005 Jun; 35(6):329-34. PubMed ID: 16039819
[TBL] [Abstract][Full Text] [Related]
59. Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
Zhanel GG; DeCorby M; Laing N; Weshnoweski B; Vashisht R; Tailor F; Nichol KA; Wierzbowski A; Baudry PJ; Karlowsky JA; Lagacé-Wiens P; Walkty A; McCracken M; Mulvey MR; Johnson J; ; Hoban DJ
Antimicrob Agents Chemother; 2008 Apr; 52(4):1430-7. PubMed ID: 18285482
[TBL] [Abstract][Full Text] [Related]
60. Overexpression of OqxAB and MacAB efflux pumps contributes to eravacycline resistance and heteroresistance in clinical isolates of Klebsiella pneumoniae.
Zheng JX; Lin ZW; Sun X; Lin WH; Chen Z; Wu Y; Qi GB; Deng QW; Qu D; Yu ZJ
Emerg Microbes Infect; 2018 Aug; 7(1):139. PubMed ID: 30068997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
